Clinical Trial Update: CT 327 in the Treatment of Psoriasis Vulgaris [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of CT 327 for psoriasis vulgaris has completed, sponsored by Creabilis SA. The snippet does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• CT 327

Snippet

Sponsor: Creabilis SA | Conditions: Psoriasis | Phase 2 | Status: COMPLETED